Personalizing Ovarian Cancer: Knowing your Genetics - Beth Karlan, MD | UCLAMDChat

UCLA gynecologic oncologist Beth Karlan, MD, gives an overview of state-of-the-art treatments for ovarian cancer and what’s different about hereditary ovarian cancer. Dr. Karlan discusses indications for genetic testing, the role of tumor molecular profiling in improving the survival for patients and their families, and targeted therapeutic options including PARP inhibitors, immunotherapy and clinical trials. #UCLAMDChat

Learn more: http://obgyn.ucla.edu/